Literature DB >> 19513777

[Atrial fibrillation ablation: who comes into consideration?].

B-D Gonska1, H J Bauerle, T Japha.   

Abstract

Atrial fibrillation ablation is, since the introduction of the guidelines in 2006 and which were updated in 2007, now a standard procedure in many electrophysiological centers. Pulmonary vein isolation has proven itself as a way to eliminate focal triggers. From pathophysiological studies of atrial fibrillation development, it is known that ablation performed early in paroxysmal atrial fibrillation has the highest chance for success. In patients with persistent or permanent atrial fibrillation, success rates are lower and repeat interventions are needed more often. Therefore, continuation of antiarrhythmic drug therapy is often necessary in these patient groups. Thus, the curative use of ablation for atrial fibrillation is only possible with the current techniques for patients with paroxysmal atrial fibrillation.

Entities:  

Mesh:

Year:  2009        PMID: 19513777     DOI: 10.1007/s00399-009-0043-8

Source DB:  PubMed          Journal:  Herzschrittmacherther Elektrophysiol        ISSN: 0938-7412


  58 in total

1.  Coronary sinus as an arrhythmogenic structure.

Authors:  Peng-Sheng Chen; Chung-Chuan Chou
Journal:  J Cardiovasc Electrophysiol       Date:  2002-09

Review 2.  Should atrial fibrillation ablation be considered first-line therapy for some patients? Why atrial fibrillation ablation should be considered first-line therapy for some patients.

Authors:  Atul Verma; Andrea Natale
Journal:  Circulation       Date:  2005-08-23       Impact factor: 29.690

Review 3.  [Nightmares in atrial fibrillation ablation--identification, management, and prevention of complications in radiofrequency ablation of atrial fibrillation].

Authors:  M Martinek; H Pürerfellner
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2007-12

4.  Successful radiofrequency ablation in patients with previous atrial fibrillation results in a significant decrease in left atrial size.

Authors:  Willem P Beukema; Arif Elvan; Hauw T Sie; Anand R Ramdat Misier; Hein J J Wellens
Journal:  Circulation       Date:  2005-10-04       Impact factor: 29.690

5.  Clinical outcome after radiofrequency catheter ablation of focal atrial fibrillation triggers.

Authors:  E P Gerstenfeld; P Guerra; P B Sparks; K Hattori; M D Lesh
Journal:  J Cardiovasc Electrophysiol       Date:  2001-08

6.  Electrophysiological breakthroughs from the left atrium to the pulmonary veins.

Authors:  M Haïssaguerre; D C Shah; P Jaïs; M Hocini; T Yamane; I Deisenhofer; M Chauvin; S Garrigue; J Clémenty
Journal:  Circulation       Date:  2000-11-14       Impact factor: 29.690

7.  Pulmonary vein isolation for paroxysmal and persistent atrial fibrillation.

Authors:  Hakan Oral; Bradley P Knight; Hiroshi Tada; Mehmet Ozaydin; Aman Chugh; Sohail Hassan; Christoph Scharf; Steve W K Lai; Radmira Greenstein; Frank Pelosi; S Adam Strickberger; Fred Morady
Journal:  Circulation       Date:  2002-03-05       Impact factor: 29.690

8.  Left atrial-esophageal fistula following radiofrequency catheter ablation of atrial fibrillation.

Authors:  Mauricio I Scanavacca; André D'ávila; José Parga; Eduardo Sosa
Journal:  J Cardiovasc Electrophysiol       Date:  2004-08

9.  Segmental ostial ablation to isolate the pulmonary veins during atrial fibrillation: feasibility and mechanistic insights.

Authors:  Hakan Oral; Bradley P Knight; Mehmet Ozaydin; Aman Chugh; Steve W K Lai; Christoph Scharf; Sohail Hassan; Radmira Greenstein; Jihn D Han; Frank Pelosi; S Adam Strickberger; Fred Morady
Journal:  Circulation       Date:  2002-09-03       Impact factor: 29.690

10.  Efficacy and safety of targeted focal ablation versus PV isolation assisted by magnetic electroanatomic mapping.

Authors:  Francis E Marchlinski; David Callans; Sanjay Dixit; Edward P Gerstenfeld; Robert Rho; Jian-Fang Ren; Erica Zado
Journal:  J Cardiovasc Electrophysiol       Date:  2003-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.